Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Evogene stock

Learn how to easily invest in Evogene stock.

Evogene Ltd is a biotechnology business based in the US. Evogene shares (EVGN) are listed on the NASDAQ and all prices are listed in US Dollars. Evogene employs 131 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Evogene

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EVGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Evogene stock price (NASDAQ: EVGN)

Use our graph to track the performance of EVGN stocks over time.

Evogene shares at a glance

Information last updated 2022-01-09.
Latest market close$1.57
52-week range$1.50 - $10.24
50-day moving average $2.08
200-day moving average $3.03
Wall St. target price$12.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.74

Buy Evogene shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
$125 - $625
Open and fund an account with $25,000 - $250,000+

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Evogene stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Evogene price performance over time

Historical closes compared with the close of $1.57 from 2022-01-14

1 week (2022-01-07) -2.48%
1 month (2021-12-15) -13.74%
3 months (2021-10-15) -41.42%
6 months (2021-07-16) -47.84%
1 year (2021-01-15) -74.18%
2 years (2020-01-16) -7.92%
3 years (2019-01-15) 2.0963
5 years (2017-01-12) 5.53

Evogene financials

Revenue TTM $970,000
Gross profit TTM $466,000
Return on assets TTM -24.63%
Return on equity TTM -49.08%
Profit margin 0%
Book value $1.47
Market capitalisation $67.4 million

TTM: trailing 12 months

Evogene share dividends

We're not expecting Evogene to pay a dividend over the next 12 months.

Have Evogene's shares ever split?

Evogene's shares were split on a 1:2 basis on 18 November 2013. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evogene shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Evogene shares which in turn could have impacted Evogene's share price.

Evogene share price volatility

Over the last 12 months, Evogene's shares have ranged in value from as little as $1.5 up to $10.24. A popular way to gauge a stock's volatility is its "beta".

EVGN.US volatility(beta: 0.84)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evogene's is 0.8389. This would suggest that Evogene's shares are less volatile than average (for this exchange).

Evogene overview

Evogene Ltd. , together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton.

Frequently asked questions

What percentage of Evogene is owned by insiders or institutions?
Currently 6.225% of Evogene shares are held by insiders and 15.71% by institutions.
How many people work for Evogene?
Latest data suggests 131 work at Evogene.
When does the fiscal year end for Evogene?
Evogene's fiscal year ends in December.
Where is Evogene based?
Evogene's address is: 13 Gad Feinstein Street, Rehovot, Israel, 7414002
What is Evogene's ISIN number?
Evogene's international securities identification number is: IL0011050551
What is Evogene's CUSIP number?
Evogene's Committee on Uniform Securities Identification Procedures number is: M4119S104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site